NCT01891552View on ClinicalTrials.gov

Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Colon Cancer Liver Metastasis
Trial Locations (1)

61122

Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore, Pesaro

All Listed Sponsors
lead

International Group of Endovascular Oncology

OTHER

NCT01891552 - Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab | Biotech Hunter | Biotech Hunter